Introduction
Cervical cancer is one of the most common malignant tumors in the female reproductive system, and its incidence is only secondary to breast cancer in developing countries. The occurrence of squamous cell carcinoma which is the most common histological type of cervical cancer is a dynamic and continuous process from cervical intraepithelial neoplasia (CIN) to invasive carcinoma (Muñoz et al., 2014) . With screening of cervical cancer developing extensively in recent years, the early diagnosis and treatment of cervical cancer and precancerous lesions have been improved conspicuously, but infiltration, metastasis and poor differentiation are still important reasons for postoperative recurrence and deaths of patients with cervical cancer (Liu et al., 2014; Qureshi et al., 2014) . Therefore, to investigate the infiltrative and metastatic mechanisms of cervical cancer is of great importance for its treatment and prognosis.
Epithelial-mesenchymal transition (EMT) is a key step in the process of cancer metastasis (Beuran et al., 2015) . Increase of Vimentin expression and decrease of E-cadherin expression are the major indexes for EMT incidence. The study has confirmed that up-regulation of Vimentin expression in various epithelial tumors is intimately associated with the tumor migration, invasion and metastasis (Satelli et al., 2011) . Differentiation of tumor cells is mutually antagonistic to their proliferation, namely the more active the cell proliferation is, and the worse the differentiated degrees are. Ki-67, a sort of protein related to cell proliferation, can reflect the proliferative capability of tumor cells, and its expression is associated with the malignant degrees of tumor and the patient's poor diagnosis . In this study, the expression of Vimentin and Ki-67 proteins in cervical squamous cell carcinoma (CSCC) was analyzed, and their correlation with the patients' clinicopathological features was also investigated so as to provide more clinical evidences for the biological behaviors and prognostic assessment of cervical cancer.
Materials and Methods

Sample source
Fifty-seven CSCC samples archived in Department of Pathology and confirmed by two pathologists in The 
Reagent
Mouse anti-human Vimentin monoclonal antibody was purchased from Wuhan Boster Biotech Co., Ltd, and mouse anti-human Ki-67 monoclonal antibody from American ZYMED Corporation. Universal secondary antibody kits were provided by Beijing Zhongshan Golden Bridge Biotech Co., Ltd.
Immunohistochemical SP method
All samples were fixed by paraformaldehyde, embedded by paraffin and cut into slices with the thickness of 2 μm. The expression of Vimentin and Ki-67 proteins in CSCC tissue was detected using immunohistochemical SP method. Specific steps were as follows: First, the sections were given dewaxing and debenzylation to hydration by gradient xylene and alcohol; Second, the antigens were repaired with high pressure in citrate for 2 min. Endogenous catalase was sealed with 3% hydrogen peroxide for 8 min after the antigens were cooling to the room temperature; Third, primary antibodies were used for incubation, overnight, and then phosphate buffer solution (PBS) was applied to swash three times; Fourth, DAB and hematoxylin were respectively used for coloration and counterstaining after incubation for 50 min by secondary antibodies; At last, the neural resin was applied to seal the sections and staining results were observed after hydration and transparency by gradient xylene and alcohol.
Criteria on evaluation
All sections were observed and judged independently by two pathologists under the condition of unknown clinical data. The positive expression of Vimentin was defined as presence of yellow and brown yellow granules in tumor cytoplasma, while that of Ki-67 as presence of yellow and brown yellow granules in tumor nuclei. The final score of immunohistochemistry was calculated using semi-quantitative method based on staining intensity and the percentage of positive cells. Three high-power visual fields (×400) in each section were randomly selected, and 100 CSCC cells in each visual field were also selected again. First of all, the scores were made according to staining intensity, namely colorless, light yellow, brown yellow and sepia were represented by 0, 1, 2, and 3 points, respectively. Next, the scores were made again based on the percentage of positive cells, that is 0, 1, 2, 3 and 4 points were on behalf of the negative, the percentage of positive cells ≤10%, being 11%~40%, being 41%~75% and ≥76%, respectively. The product of two scores was as the final score, namely 0~1 point being negative (-), 2~3 points being weakly positive (+), 4~7 points being positive (++) and ≥8 points being strongly positive (+++).
Statistical data analysis
SPSS 15.0 software package was used for statistical analysis. The enumeration data were compared using x 2 test and expressed by percentages. Pearson correlation analysis was carried out for those with normal distribution of Ki-67 and Vimentin expression. The relationships between Ki-67, Vimentin expression and the patients' clinicopathological features were analyzed by x 2 test of the four-fold table. All statistical tests were performed in a two-sided way. P<0.05 was considered to be statistically significant.
Results
Expression of vimentin and Ki-67 in CSCC tissue
The positive signals of Vimentin were located in DOI:http://dx.doi.org/10.7314/APJCP.2015.16.10.4271 Expression of Vimentin and Ki-67 Proteins in Cervical SCC and Relationships with Clinicopathological Features cytoplasma, and it was primarily expressed in some cervical cancer cells and interstitial tissue (Figure 1) . Semi-quantitative scoring in this study was only used to calculate the cervical cancer cells. The positive signals of Ki-67 were located in nuclei, mainly manifesting brow yellow or sepia granules (v 2).
Relationship between Ki-67 expression and the clinicopathological features of patients with CSCC
Ki-67 expression was intimately associated with the presence or absence of local invasion and lymph node metastasis as well as differentiated degrees of the tumor (P=0.003, 0.017, 0.000) instead of the age, tumor size and clinical staging (P>0.05) ( Table 1) .
Relationship between Vimentin expression and the clinicopathological features of patients with CSCC
Vimentin expression was also closely related to the presence or absence of local invasion and lymph node metastasis as well as differentiated degrees of the tumor (P=0.001, 0.008, 0.003), but not to the age, tumor size and clinical staging (P>0.05) ( Table 2) .
Discussion
CSCC is one of the most common cervical cancers in female reproductive system, approximately accounting for 80% of the total (Gan et al., 2014) . According to the statistics, the newly-onset patients are about 5 million in the world every year, in which about 50% mainly focus on the developing countries. In recent years, more and more young women tend to suffer from cervical cancer (Li et al., 2009 ). There is a long period of precancerous lesions from cervical cells to cancer cells. The survival rate of patients with early cervical cancer comes up to 90%. Hence, early prevention and treatment can effectively reduce the occurrence of cervical cancer and mortality.
Cervical cancer is a sort of polygenic disease, and its occurrence is related to a lot of factors, in which the most pivotal one is continuous infection of high-risk human papilloma virus (HPV) (Gonzalez-Herrera et al., 2015). Geiger et al. found that the phenotype of epithelial cells in normal epithelial cells infected by HPV gradually disappeared, whereas EMT happened in the phenotype of some mesenchymal cells (Geiger et al., 2008) . HPV16 E7 protein can promote the transformation of human normal epithelial cells to mesenchymal cells, and its oncogene proteins can accelerate the tumor malignant transformation through induction of EMT (Hellner et al., 2009 ). In the processes of tumorigenesis and progression, the mutual actions of transcription factors, protein kinases of tumor microenvironment and other regulatory factors can result in abnormal expression of EMT-related markers. For instance, cytoskeletal rearrangement, loss expression of keratin and up-regulated expression of Vimentin can all cause cell-matrix adhesion and change cell phenotypes, consequently enhancing cell invasiveness and metastatic capability (Araki et al., 2010) . As a type III intermediate filament protein, Vimentin participates in cytoskeletal formation. As a signal factor, it takes part in crucial life activities, including gene transmission and expression as well as intracellular information transmission. Vimentin can make the epithelial cytoskeleton reconstitute via ectopic expression in epithelial tissue. After biological behaviors and morphology change, it changes into fibroblast-like cells which are easier to move so as to transform into mesenchyme, produce EMT and promote tumor invasion and metastasis. In recent years, the studies have displayed that up-regulation of Vimentin expression in cancer tissue is involved in EMT process, and infiltration and metastasis tend to appear in the tumors where EMT occurred (Xiao et al., 2012) . The study made by Cheng et al. has also confirmed that Vimentin is not expressed in normal epithelial cells, but is expressed mesenchymal cells and part of ectoderm cells. It can be considered as a specific marker for indentifying the origin of tumor differentiation (Cheng et al., 2012) . At present, there are few studies on Vimentin expression in cervical cancer. Therefore, this study detected the expression of Vimentin in CSCC tissue using immunohistochemical method, and the results showed that 43 out of 57 patients with CSCC had positive expression of Vimentin, and the positive rate was 75.4%; Vimentin expression was also closely related to the presence or absence of local invasion and lymph node metastasis as well as differentiated degrees of the tumor, indicating that EMT is present in the process of CSCC progression, and Vimentin is associated with local invasion and metastasis of cervical cancer. Ki-67, a sort of nucleoprotein related to cell proliferation, was first discovered in Hodgkin's lymphoma L428 cell lines and cloned. It is composed of two polypeptide chains (345 KD and 395 KD) and has nonhistone characteristics. The expression and localization of Ki-67 as a nuclear antigen in the cell cycle change periodically due to DNA replication. It can accurately reflect the phase of cell proliferation, namely it begins to express in phase G1 and reduces immediately after mitosis, but not express in phase G0 . As one of the most extensively-applied cell proliferation markers, Ki-67 is regarded as a more reliable marker that can comprehensively reflect the activity of cell proliferation. It can quantitatively analyze the growth fraction and is of great importance in the tumor grading, proliferative degrees and prognosis Kontzoglou et al., 2013) . A lot of studies displayed that Ki-67 was highly expressed in a variety of gynecological malignant tumors, such as ovarian cancer, endometrial carcinoma and breast cancer, and was related to the tumor occurrence, progression, invasion and metastasis intimately (Kilickap et al., 2014; Kucukgoz et al., 2014; Shevra et al., 2015) . The research results in this study revealed that 57 patients with CSCC all had positive expression of Ki-67, and the positive rate came up to 100.0%; Ki-67 was positively correlated with Vimentin expression. Additionally, Ki-67 expression was intimately associated with the presence or absence of local invasion and lymph node metastasis as well as differentiated degrees of the tumor. All these results suggest that the differentiated degrees of tumor are related to occurrence of EMT, and EMT tends to appear in the poorly-differentiated tumor tissue.
To sum up, EMT is present in the process of CSCC progression and tends to appear in the poorly-differentiated tumor tissue. Up-regulation of Vimentin expression in CSCC tissue is accompanied by high expression of Ki-67, suggesting that invasion and metastasis are easy to occur in these tumor cells. Combined application of Vimentin and Ki-67 in the postoperative pathological diagnosis is of great importance for judging the biological behaviors of cervical cancer and patients' prognosis.
